
    
      Patient Population: Age: 18-70y; Thoracic esophageal squamous cell cancer undergoing radical
      esophagectomy; Clinical stage T1-4, N1-3, M0; Eastern Cooperative Oncology Group (ECOG)
      score: 0-1; The patients are randomized to 2 arms. Arm A: Adjuvant radiotherapy
      (50.4gray/28fraction) followed by chemotherapy (Paclitaxel and carboplatin) 4 cycles. Arm B
      :Adjuvant radiotherapy (50.4gray/28fraction) only
    
  